These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22388526)

  • 1. Economic grand rounds: economic costs of failure to monitor adverse effects of second-generation antipsychotics: an underestimated factor.
    Jerrell JM; McIntyre RS; Black GB
    Psychiatr Serv; 2012 Mar; 63(3):202-4. PubMed ID: 22388526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic grand rounds: systemwide costs associated with second-generation antipsychotics in the treatment of schizophrenia.
    Sernyak MJ; Rosenheck R
    Psychiatr Serv; 2004 Dec; 55(12):1361-2. PubMed ID: 15572563
    [No Abstract]   [Full Text] [Related]  

  • 4. Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices.
    Mitchell AJ; Delaffon V; Vancampfort D; Correll CU; De Hert M
    Psychol Med; 2012 Jan; 42(1):125-47. PubMed ID: 21846426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic monitoring for patients treated with antipsychotic medications.
    Cohn TA; Sernyak MJ
    Can J Psychiatry; 2006 Jul; 51(8):492-501. PubMed ID: 16933586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient, Treatment, and Health Care Utilization Variables Associated with Adherence to Metabolic Monitoring Practices in Children and Adolescents Taking Second-Generation Antipsychotics.
    Coughlin M; Goldie CL; Tranmer J; Khalid-Khan S; Tregunno D
    Can J Psychiatry; 2018 Apr; 63(4):240-249. PubMed ID: 29528720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiometabolic comorbidity in antipsychotic treated patients: need for systematic evaluation and treatment.
    Steylen PM; van der Heijden FM; Kok HD; Sijben NA; Verhoeven WM
    Int J Psychiatry Clin Pract; 2013 Jun; 17(2):125-30. PubMed ID: 23437800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guideline adherence for cardiometabolic monitoring of patients prescribed antipsychotic medications in primary care: a retrospective observational study.
    Ali RA; Jalal Z; Johal J; Paudyal V
    Int J Clin Pharm; 2023 Oct; 45(5):1241-1251. PubMed ID: 37755643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-cost use of second-generation antipsychotics under California's Medicaid program.
    Stahl SM; Grady MM
    Psychiatr Serv; 2006 Jan; 57(1):127-9. PubMed ID: 16399974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions to Improve Metabolic Risk Screening Among Adult Patients Taking Antipsychotic Medication: A Systematic Review.
    Melamed OC; Wong EN; LaChance LR; Kanji S; Taylor VH
    Psychiatr Serv; 2019 Dec; 70(12):1138-1156. PubMed ID: 31522630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and costs of cardiometabolic conditions in patients with schizophrenia treated with antipsychotic medications.
    Jerrell JM; McIntyre RS; Tripathi A
    Clin Schizophr Relat Psychoses; 2010 Oct; 4(3):161-8. PubMed ID: 20880826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic screening in children receiving antipsychotic drug treatment.
    Morrato EH; Nicol GE; Maahs D; Druss BG; Hartung DM; Valuck RJ; Campagna E; Newcomer JW
    Arch Pediatr Adolesc Med; 2010 Apr; 164(4):344-51. PubMed ID: 20368487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of cardiovascular outcomes and diabetes mellitus among users of second-generation antipsychotics.
    Citrome L; Collins JM; Nordstrom BL; Rosen EJ; Baker R; Nadkarni A; Kalsekar I
    J Clin Psychiatry; 2013 Dec; 74(12):1199-206. PubMed ID: 24434088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the costs of second-generation antipsychotics.
    Pfeiffer PN; Valenstein M
    Psychiatr Serv; 2012 Mar; 63(3):199. PubMed ID: 22388524
    [No Abstract]   [Full Text] [Related]  

  • 15. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.
    Loosbrock DL; Zhao Z; Johnstone BM; Morris LS
    J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of antipsychotic medication on psychiatric service utilization and cost.
    Rothbard A; Murrin MR; Jordan N; Kuno E; McFarland BH; Stroup TS; Morrissey JP; Stiles PG; Boothroyd RA; Merwin E; Shern DL
    J Ment Health Policy Econ; 2005 Jun; 8(2):83-93. PubMed ID: 15998980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between class of antipsychotic and rates of hospitalization: results of a retrospective analysis of data from the 2005 Medicare current beneficiary survey.
    Kennedy J; Tien YY; Cohen LJ; Sclar DA; Liu D; Blodgett EG; Engle J
    Clin Ther; 2009 Dec; 31(12):2931-9. PubMed ID: 20110033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and characteristics of emergency departments visits by US adults with psychiatric disorder and antipsychotic mention from 2000 to 2004.
    Sankaranarayanan J; Puumala SE
    Curr Med Res Opin; 2007 Jun; 23(6):1375-85. PubMed ID: 17594776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: a review for primary care physicians.
    Hasnain M; Vieweg WV; Hollett B
    Postgrad Med; 2012 Jul; 124(4):154-67. PubMed ID: 22913904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicians' adherence to clinical practice guidelines for cardiac function monitoring during antipsychotic treatment: a retrospective report on 434 patients with severe mental illness.
    Manchia M; Firinu G; Carpiniello B; Pinna F
    BMC Psychiatry; 2017 Mar; 17(1):121. PubMed ID: 28359306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.